RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Return on equity (%)

REGENERON PHARMACEUTICALS, INC.【REGN】

Market cap
$86B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 202416-1.91%
Dec 31, 202316.3-22.35%
Dec 31, 202220.9-61.37%
Dec 31, 202154.2+70.63%
Dec 31, 202031.8+49.02%
Dec 31, 201921.3-35.02%
Dec 31, 201832.8+44.98%
Dec 31, 201722.6+2.40%
Dec 31, 201622.1+7.65%
Dec 31, 201520.5+32.54%
Dec 31, 201415.5-41.64%
Dec 31, 201326.5-69.38%
Dec 31, 201286.7-298.08%
Dec 31, 2011-43.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)